Barron's

Syndicate content Barron's Features
Barron's Features
Updated: 9 min 16 sec ago

The Best Ways to Bet on Puerto Rico Now

Mon, 06/27/2016 - 20:39
Holders of the general-obligation paper are likely to do best in a debt restructuring.

Tractor Supply Rides the Hobbyist Farming Wave

Sat, 06/25/2016 - 10:52
The company’s shares could keep rising as more retirees try farming. Why chicken feed is big money.

Battered Goldman Sachs Poised for Rebound

Sat, 06/25/2016 - 10:50
The markets have been unkind, but buybacks, cost cutting, and steady revenues could lift stock by 25%.

Brexit Selloff Highlights Strength of U.S. Market

Sat, 06/25/2016 - 10:38
U.S. companies depend on domestic customers, which helps to insulate them from problems abroad.

New Rule Could Improve Annuities

Sat, 06/25/2016 - 10:26
SPECIAL REPORT -- Retirement: The Department of Labor’s new fiduciary rule means that people selling annuities will have to be a lot more transparent about how they’re getting paid, and why the product they chose for a client really is the right one.

Top 50 Annuities for 2016

Sat, 06/25/2016 - 10:25
SPECIAL REPORT -- Retirement: Annuities are about to get a makeover—new rules, low interest rates, and longer lives are shaping new products. Our annual ranking will point you to the best choices.

Square Stock Likely To Set New Lows

Fri, 06/24/2016 - 22:23
A once sought-after unicorn, the payment processor is growing fast but faces a tough path to profitability.

Brexit Win Stuns World; Dow Seen Down By 600

Fri, 06/24/2016 - 10:16
In a historic upset, the U.K. is seen as having voted to leave the EU, sending global markets into free fall.

Brexit: Stocks Look Cheap If 'Remain' Vote Prevails

Fri, 06/24/2016 - 01:39
If Britain votes to stay in the European Union, a worldwide relief rally looks to be likely.

Auto-Parts Supplier Delphi Hits the Fast Lane

Tue, 06/21/2016 - 00:49
Profits are rising as it helps make cars safer, cleaner, and smarter. Stock could pop more than 60%.

Celgene: More Than a One-Drug Wonder

Tue, 06/21/2016 - 00:48
The biotech sees a decade of growth in its blockbuster, Revlimid. And it’s aggressively spending on R&D.

Our Top 100 Hedge Funds

Mon, 06/20/2016 - 12:36
Appaloosa and Citadel return, but the surprise No. 1 on the Barron’s Penta list is a low profile Hong Kong-based hedge fund with 30% returns.

McKesson Shares Could Rise 15% or More

Mon, 06/13/2016 - 19:55
The drug wholesaler is gaining clients and expanding its lucrative specialty-drug business.

LyondellBasell Offers a 4.2% Yield and Upside

Sat, 06/11/2016 - 13:37
The petrochem giant’s stock is down 20% as rivals add capacity. But cost efficiency could boost shares 20%.

Time to Mend the GAAP

Sat, 06/11/2016 - 13:36
Co-authors Baruch Lev and Feng Gu claim accounting hasn’t kept pace with a changed economy that emphasizes intangible assets.

Retailer Williams-Sonoma Is "Amazon-Proof"

Sat, 06/11/2016 - 13:30
More than half of Williams-Sonoma’s sales are online. Why the shares could return more than 25% in a year.

Oaktree Capital's Outlook Is Brightening

Wed, 06/08/2016 - 00:45
The alternative asset manager is ready to capitalize on a boom in distressed debt. Stock is worth $60.

Healthy Gains Ahead for Whole Foods

Mon, 06/06/2016 - 23:40
Whole Foods is cutting costs and rolling out a smaller, lower-priced version of its stores.

Time to Reel In Profits on Cabela's Shares

Mon, 06/06/2016 - 23:38
Speculation about a sale of the outdoor-gear retailer has pushed the stock too high.

J&J Supplants Apple as Barron's Most Respected Company

Sat, 06/04/2016 - 13:46
Tech giant falls to third, as Berkshire Hathaway takes No. 2 spot.